Dr. Marto is a Principal Investigator at the Dana-Farber Cancer Institute and holds a joint appointment as Associate Professor of Pathology at the Brigham and Women’s Hospital and Harvard Medical School. Dr. Marto is internationally recognized for his expertise in the development and use of state-of-the-art mass spectrometry and other bio-analytical techniques to characterize cellular communication pathways that underlie normal physiology and human disease.  Dr. Marto’s lab pursues technology development with the primary objective of using quantitative mass spectrometry for analysis of primary human tissues and other high-fidelity model systems.  These research efforts are further enabled by development of software and computation tools that facilitate analysis of the associated data across the full spectrum of scientific inquiry, from the fundamental measurements and instrumentation, to interpretation of quantitative protein-level data in the context of biological pathways. Dr. Marto’s portfolio of publications span basic chemistry, analytical science, advanced instrumentation, mass-/bio-informatics, and human biology.